Send to a Friend

Your name*

Your email adress*

Your friend's email address*


About Access to Insight

The Novo Nordisk Access to Insight initiative seeks to promote innovative haemostatic research in rare bleeding disorders.

The Basic Research Grant will support research projects focusing on basic and translational research in haemostasis and the Clinical Research Grant will support innovative haemostatic research on patient outcomes, quality of life, and social impacts.

The funding will be available for expenses directly related to the implementation of the project. Funding will be transferred to the institution and not to the applicant.

Application review process

All completed applications that are submitted by the deadline, fit the research scope, and meet the formal application criteria will be reviewed by Review Board Members and thereafter the Core Faculty Members.

Each application will be reviewed according to objective scientific criteria. Although the Core Faculty members representing Novo Nordisk will provide comments for consideration, the independent Core Faculty members and the Review Board will be completely autonomous in determining the winners to ensure a fair and transparent selection process.

General application criteria

General application process
The application flow chart "Your way to funding opportunities" will guide you through the application process.

Please download Application process here

Applicants should submit the following application documents:

  • Cover letter
  • Curriculum vitae
  • Application form (including requested materials)

Please download Application form here


December 1st, 2023
Open for Applications
April 1st, 2024
Application Deadline
April-May 2024
Review and Selection
July 2024
Notification of recipient
September 2024
Funding Available



If you are interested in
receiving the Newsletter,
please sign up.